Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Bayer

company

About

Bayer is a life science company that specializes in the areas of health care and agriculture.

Details

Last Funding Type
Grant
Last Funding Money Raised
$12M
Industries
Biotechnology,Chemical,Health Care,Life Science,Pharmaceutical
Founded date
Jan 1, 1863
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
etr:BAYN
Legal Name
Bayer AG
Sub-Organizations
Bayer Open Innovation

Bayer is an enterprise with core competencies in the life science fields of healthcare and nutrition. They design their products and services to help people and the planet thrive by supporting efforts to address unprecedented challenges. Their businesses include pharmaceuticals, consumer health, and crop science. They focus on developing and commercializing products and solutions based on scientific knowledge.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$12M €3B
Bayer has raised a total of $12M €3B in funding over 2 rounds. Their latest funding was raised on Nov 8, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 8, 2022 Grant $12M 1 Bill & Melinda Gates Foundation Detail
Apr 17, 2018 Post-IPO Equity €3B 1 Temasek Holdings Detail
Oct 2, 2009 IPO Detail

Investments

Number of Investments
Number of Lead Investments
30
13
Bayer has made 30 investments. Their most recent investment was on Jun 20, 2022, when OME Health raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 20, 2022 OME Health
Seed Analytics
Mar 1, 2021 Grão Direto
Series Unknown R$18M Agriculture
Nov 17, 2020 Elly
Series Unknown Health Care
Aug 24, 2020 OneDrop
Series C $34.70M Apps Yes
Feb 27, 2020 Oerth Bio
Corporate Round $55M Biotechnology

Investors

Number of Lead Investors
Number of Investors
2
2
Bayer is funded by 2 investors. Bill & Melinda Gates Foundation and Temasek Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
Bill & Melinda Gates Foundation Yes Grant
Temasek Holdings Yes Post-IPO Equity

Employee Profiles

Number of Employee Profiles
61
Bayer has 61 current employee profiles, including Employee Kate Humphrey
Employee
Executive
Executive
Executive

Exits

Bayer has had 2 exits. Bayer most notable exits include Covercress ,   BlueRock Therapeutics

Date Company Name Exit Type Industry
Aug 1, 2022 Covercress M&A Animal Feed Detail
Aug 8, 2019 BlueRock Therapeutics M&A Biopharma Detail

Acquisition

Bayer has acquired 16 organizations. Their most recent acquisition was Zeptosens on Mar 9, 2005. They acquired Zeptosens for 0.

Date Company Name
Industry Acquisition Type Price
Mar 9, 2005 Zeptosens
Biotechnology Detail
Feb 13, 2006 Icon Genetics
Agriculture Detail
Electronics acquisition Detail
Jul 1, 2012 AgraQuest
Agriculture acquisition $ 425M Detail
Dec 19, 2013 Algeta
Biotechnology acquisition $ 2.90B Detail